“Breast Cancer Talk”: Nursing Perspectives on HER2-Targeted Agents in Breast Cancer - Episode 4

Management of Adverse Effects in R/R HER2+ mBC

, , ,

Counseling patients and the management of adverse effects of newer regimens in relapsed/refractory HER2+ metastatic breast cancer as well as advice for oncology nurses.